We're here for one reason and one reason only - to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.
Job Description
US Medical Affairs - Cell Therapy / Multiple Myeloma
Location: United States (Field-Based)
Reports to: Head, US Clinical Value & Market Expansion (Medical Affairs)
Role Purpose
The Director, Clinical Value Liaison (CVL) is a senior field-based medical leader responsible for advancing clinical value, access, and appropriate adoption of cell therapy across complex healthcare ecosystems.
This role operates within Medical Affairs and engages with payers, authorized treatment centers, and community oncology practices to address clinical, economic, and system-level barriers that impact patient access and outcomes.
The CVL complements Medical Science Liaisons (MSLs) by focusing on system-level value conversations-including evidence needs, referral pathways, site readiness, and community oncology enablement-while maintaining strict non-promotional boundaries.
This position will support the following: Gulf Coast, South Central, Great Lakes, and North Central Regions - Alabama, Georgia, North Carolina, South Carolina, Mississippi, Louisiana, Texas (Central & East), Michigan, North Illinois (includes Chicago area), Wisconsin, Minnesota, North Dakota, South Dakota, Iowa, Nebraska, Kansas, Missouri, South Illinois, Oklahoma, Arkansas.
Key Responsibilities
Population Health & Payer Medical Engagement
Serve as the primary Medical Affairs interface to population health decision-makers, including:
National and regional payer medical leadership
Health system executives
Network-level pharmacy and utilization management stakeholders
Deliver scientific exchange focused on clinical, HEOR, and RWE to support payer and health system decision making.
Partner with HEOR and Evidence Generation teams to identify evidence gaps and inform RWE strategies relevant to coverage, reimbursement, and population-based care.
Community Oncology & Market Expansion
Advance appropriate cell therapy adoption in community oncology settings, including:
Supporting ATC-community referral pathways
Enabling decentralized and outpatient care models
Identifying system-level barriers to timely referral and treatment
Engage with community oncology practices to provide clinical, RWE, cost of care data to support onboarding discussion.
Collaborate with MSLs and Field Directors to coordinate customer engagement within shared ecosystems and facilitate exchange of clinical and access insights.
Cross-Functional Medical Leadership
Act as a medical thought partner to:
Market Access and Account Directors
HEOR / RWE / Evidence Generation functions
Global Medical Affairs and portfolio strategy partners
Contribute medical leadership to integrated ecosystem planning, ensuring alignment between scientific evidence, access needs, and care delivery realities.
Insights, Strategy & Execution
Capture structured medical insights related to:
Unmet evidence needs across customer segments
Community oncology clinical, operational, and financial barriers
Real-world utilization and outcomes trends
Translate insights into actionable recommendations for Medical Affairs leadership, evidence generation, and market expansion strategy.
Support launch readiness and lifecycle planning through field-informed medical strategy execution.
Governance, Compliance & Ways of Working
Conduct all engagements in full compliance with:
Medical governance standards
Scientific exchange and non-promotional guidance
Model best-in-class Medical Affairs ways of working, serving as a role model for ethical, patient-centric engagement.
Qualifications
Required
Advanced scientific or clinical degree (PharmD, PhD, MD, or equivalent)
8+ years experience in US Medical Affairs, health economics, outcomes research, or payer-facing roles
Deep understanding of US payer dynamics, population health decision-making, and oncology care delivery
Preferred
Cell therapy and/or Multiple Myeloma experience
Experience engaging community oncology networks and health systems
Familiarity with RWE, HEOR, and outcomes-based evidence discussions
Core Competencies
Scientific and clinical credibility
Population-level thinking and systems mindset
Cross-functional influence without authority
Strategic insight generation
Comfort operating in ambiguity and evolving market models
People Leader Accountabilities
Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
Develop Talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and realize their purpose.
Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.
The salary range for this position is: $221,000.00 - $286,000.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.
For additional benefits information, visit:
https://www.gilead.com/careers/compensation-benefits-and-wellbeing
Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.
Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com . Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma .
For jobs in the United States:
Kite Pharma is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact ApplicantAccommodations@gilead.com for assistance.
For more information about equal employment opportunity protections, please view the 'Know Your Rights' (https://www.eeoc.gov/employers/eeo-law-poster) poster.
NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT (http://www.dol.gov/whd/regs/compliance/posters/eppac.pdf)
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT
Kite Pharma will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.
Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.
Kite Pharma provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.
For Current Kite Pharma Employees and Contractors:
Please apply via the Internal Career Opportunities portal in Workday.
Change The World With Us
Everyone at Kite is grounded by one common goal - curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work.
We are creating Kite together, with the recognition that the best teams are built by the best people. We maintain an attitude of curiosity, and creativity with each challenge as we develop a new market for cancer therapies. We appreciate and respect one another, and most importantly, we don't take success for granted.
While we've come a long way to make what others viewed as impossible, possible, we know one thing is certain. Today is just the beginning.
